Feb 14, 2022OnQuality Pharmaceuticals to Present NOVA-II Phase 2 Trial Update and Oncologist Survey at ASCO GU- OnQuality will present an update on its NOVA-II Phase 2 clinical trial investigating OQL011, a proprietary ointment designed to treat...
Jan 19, 2022OnQuality Pharmaceuticals to Present Oncologist Survey Data Demonstrating Need for [...]Full Title: OnQuality Pharmaceuticals to Present Oncologist Survey Data Demonstrating Need for New Cancer Therapy-Associated Diarrhea...
Jan 4, 2022OnQuality Pharmaceuticals Reports Topline Data from Phase 2 Trial of Treatment for Cancer [...]Therapy Induced Skin Toxicity that Met Expectations - Part 1 of the Phase 2 NOVA-II clinical trial evaluating OQL011 met the company's...
Sep 7, 2021OnQuality Pharmaceuticals Announces Completion of Part 1 of NOVA-II Trial - Top-line readout of clinical study results anticipated by the end of 2021 SEATTLE, Sept. 7, 2021 /PRNewswire/ -- OnQuality...
Jun 9, 2021OnQuality Pharmaceuticals Announces Upcoming Presentation at 2021 BIO DigitalSEATTLE, June 9, 2021 /PRNewswire/ -- OnQuality Pharmaceuticals ("OnQuality"), a targeted cancer supportive care company developing...
May 19, 2021OnQuality Pharmaceuticals to Present on NOVA-II Trial Evaluating OQL011 at the 2021 ASCO and MASCCOnQuality Pharmaceuticals to Present on NOVA-II Trial Evaluating OQL011 at the 2021 ASCO and MASCC/ISOO Annual Meetings SEATTLE, May 19,...